ALX Oncology (ALXO)
Develops evorpacept and ALX2004 for clinical-stage cancer studies.
$2.01
Pre-market−0.07 (−3.37%)
At close$2.08(+5.05%)
Something off on this page? Send us feedback.
Next report
Nov 6, 2026
in 64 days
EPS estimate
−$0.15
Revenue estimate
—
Fiscal quarter
Q3 FY26
EPSReportedEstimate
Mar '25May '25Aug '25Nov '25Feb '26May '26Aug '26Nov '26
Reported−$0.55−$0.58−$0.49−$0.41−$0.42−$0.17−$0.13Pending
Estimate−$0.72−$0.47−$0.46−$0.37−$0.38−$0.15−$0.14−$0.15
Surprise+23.6%−23.4%−6.5%−10.8%−10.5%−13.3%+9.0%—
RevenueReportedEstimate
Mar '25May '25Aug '25Nov '25Feb '26May '26Aug '26Nov '26
Reported———————Pending
Estimate————————
Surprise————————
History
| Date | Estimate | Reported | Surprise |
|---|---|---|---|
| Nov 2026 | −$0.15 | — | — |
| Aug 2026 | −$0.14 | −$0.13 | +9.0% |
| May 2026 | −$0.15 | −$0.17 | −13.3% |
| Feb 2026 | −$0.38 | −$0.42 | −10.5% |
| Nov 2025 | −$0.37 | −$0.41 | −10.8% |
The latest year is open to everyone — the 26 quarters behind it read with an account. Sign in | |||
| Aug 2025 | |||
| May 2025 | |||
| Mar 2025 | |||
| Nov 2024 | |||
| Aug 2024 | |||
| May 2024 | |||
| Mar 2024 | |||
| Nov 2023 | |||
| Aug 2023 | |||
| May 2023 | |||
| Mar 2023 | |||
| Nov 2022 | |||
| Aug 2022 | |||
| May 2022 | |||
| Feb 2022 | |||
| Nov 2021 | |||
| Aug 2021 | |||
| May 2021 | |||
| Mar 2021 | |||
| Nov 2020 | |||
| Aug 2020 | |||
| Jul 2020 | |||
| Dec 2019 | |||
| Sep 2019 | |||
| Jun 2019 | |||
| Mar 2019 | |||
| Report date | EPS est | EPS | Surprise | Revenue est | Revenue | Surprise | Reaction |
|---|---|---|---|---|---|---|---|
| Nov 6, 2026 | −$0.15 | — | — | — | — | — | — |
| Aug 6, 2026 | −$0.14 | −$0.13 | +9.0% | — | — | — | +9.9% |
| May 8, 2026 | −$0.15 | −$0.17 | −13.3% | — | — | — | 0.0% |
| Feb 27, 2026 | −$0.38 | −$0.42 | −10.5% | — | — | — | +0.5% |
| Nov 7, 2025 | −$0.37 | −$0.41 | −10.8% | — | — | — | −8.0% |
The latest year is open to everyone — the 26 quarters behind it read with an account. Sign in | |||||||
| Aug 12, 2025 | |||||||
| May 8, 2025 | |||||||
| Mar 6, 2025 | |||||||
| Nov 7, 2024 | |||||||
| Aug 8, 2024 | |||||||
| May 9, 2024 | |||||||
| Mar 7, 2024 | |||||||
| Nov 13, 2023 | |||||||
| Aug 10, 2023 | |||||||
| May 11, 2023 | |||||||
| Mar 9, 2023 | |||||||
| Nov 8, 2022 | |||||||
| Aug 8, 2022 | |||||||
| May 9, 2022 | |||||||
| Feb 28, 2022 | |||||||
| Nov 11, 2021 | |||||||
| Aug 12, 2021 | |||||||
| May 17, 2021 | |||||||
| Mar 18, 2021 | |||||||
| Nov 12, 2020 | |||||||
| Aug 27, 2020 | |||||||
| Jul 17, 2020 | |||||||
| Dec 31, 2019 | |||||||
| Sep 30, 2019 | |||||||
| Jun 30, 2019 | |||||||
| Mar 31, 2019 | |||||||